🇧🇷 Dupixent in Brazil

Dupixent (DUPILUMAB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Dupixent in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Brazil

Frequently asked questions

Is Dupixent approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Dupixent in Brazil?

Regeneron is the originator. The local marketing authorisation holder may differ — check the official source linked above.